19-Nov-2021 - Rheinische Friedrich-Wilhelms-Universität Bonn

New group of antibacterial molecules identified

International research group discovers promising scaffold for antimicrobial agents

Researchers at Karolinska Institutet, Umeå University, and the University of Bonn have identified a new group of molecules that have an antibacterial effect against many antibiotic-resistant bacteria. Since the properties of the molecules can easily be altered chemically, the hope is to develop new, effective antibiotics with few side effects.

The increasing resistance to antibiotics in the world is alarming while few new types of antibiotics have been developed in the past 50 years. There is therefore a great need to find new antibacterial substances.

The majority of antibiotics in clinical use work by inhibiting the bacteria's ability to form a protective cell wall, causing the bacteria to crack (cell lysis). Besides the well-known penicillin, that inhibits enzymes building up the wall, newer antibiotics such as daptomycin or the recently discovered teixobactin bind to a special molecule, lipid II. Lipid II is needed by all bacteria, to build up the cell wall. Antibiotics that bind to this cell wall building block are usually very large and complex molecules and therefore more difficult to improve with chemical methods. These molecules are in addition mostly inactive against a group of problematic bacteria, which are surrounded by an additional layer, the outer membrane, that hinders penetration of these.

“Lipid II is a very attractive target for new antibiotics. We have identified the first small antibacterial compounds that work by binding to this lipid molecule, and in our study, we found no resistant bacterial mutants, which is very promising,” says Birgitta Henriques Normark, professor at the Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet.

In this study, researchers at Karolinska Institutet and Umeå University in Sweden have tested a large number of chemical compounds for their ability to lyse pneumococci, bacteria that are the most common cause of community-acquired pneumonia. The initial tests were carried out in collaboration with the Chemical Biology Consortium Sweden (CBCS), a national research infrastructure at SciLifeLab. After a careful follow-up of active compounds from this screening, the researchers, in collaboration with the University of Bonn in Germany, found that a group of molecules called THCz inhibits the formation of the cell wall of the bacterium by binding to lipid II. The molecules could also prevent the formation of the sugar capsule that pneumococci need to escape the immune system and cause disease.

Molecules that are easy to modify chemically

“The advantage of small molecules like these is that they are more easy to change chemically. We hope to be able to change THCz so that the antibacterial effect increases and any negative effects on human cells decrease,” says Fredrik Almqvist, professor at the Department of Chemistry at Umeå University.

In laboratory experiments, THCz have an antibacterial effect against many antibiotic-resistant bacteria, such as methicillin-resistant staphylococci (MRSA), vancomycin-resistant enterococci (VRE), and penicillin-resistant pneumococci (PNSP). An antibacterial effect was also found against gonococci, which causes gonorrhoea, and mycobacteria, bacteria that can cause severe diseases such as tuberculosis in humans. The researchers were unable to identify any bacteria that developed resistance to THCz in a laboratory environment.

“We will now also initiate attempts to change the THCz molecule, allowing it to penetrate the outer cell membrane found in some, especially intractable, multi-resistant bacteria,” says Tanja Schneider, professor at the Institute of Pharmaceutical Microbiology at the University of Bonn.

Rheinische Friedrich-Wilhelms-Universität Bonn

Recommend news PDF version / Print

Share on

Facts, background information, dossiers
  • antibiotics
  • antibiotic resistance
More about Universität Bonn
  • News

    Researchers film fundamental life process

    All proteins in a cell are assembled by complicated molecular machines. The precursors of these ribosomes are produced in the cell nucleus and then enter the cell through the so-called nuclear pores. Researchers at the University of Bonn and ETH Zurich have now filmed this fundamental proce ... more

    Artificial intelligence helps diagnose leukemia

    The presence of cancer of the lymphatic system is often determined by analyzing samples from the blood or bone marrow. A team led by Prof. Dr. Peter Krawitz from the University of Bonn had already shown in 2020 that artificial intelligence can help with the diagnosis of such lymphomas and l ... more

    Novel method for fast 3D microscopy

    Researchers at the ImmunoSensation2 Cluster of Excellence at the University of Bonn, the University Hospital and the research center caesar have develop a method that allows using multi-focal images to reconstruct the movement of fast biological processes in 3D. In the past, many discoveri ... more

More about Karolinska Institutet
  • News

    New insight into cell receptors opens the way for tailored cancer drugs

    New research on how cancer mutations influence a certain type of receptor on the cell membrane opens the way for the development of tailored drugs for certain cancers, such as rectal cancer and lung cancer. This according to researchers at Sweden's Karolinska Institutet and Uppsala Universi ... more

    Nobel Prize for Physiology or Medicine 2018 Announced

    The researchers James P. Allison and Tasuku Honjo were announced today as this year's winners of the Nobel Prize for Physiology or Medicine. Their achievements in the field of cancer therapy was groundbreaking and worthy of the Nobel Prize Committee's appreciation. With the help of the immu ... more

    The Nobel Prize Winners 2017

    This year's Nobel Prizes were awarded to a total of nine scientists. The research areas that have been awarded and the prize winners at a glance: Nobel Prize for Physiology or Medicine The Nobel Committee at the Karolinska Institute has awarded the Nobel Prize in Physiology or Medicine to t ... more

More about Umeå universitet
  • News

    Membrane vesicles released by bacteria may play different roles during infection

    Bacteria release membrane-derived vesicles (MVs), which are small particles that can transport virulence factors to neighbouring bacteria or to the cells of a mammalian host. This special MV-based system for delivering toxic proteins and nucleic acids in a protected manner to the target cel ... more

    Spotting the invisible

    Chemists at Umeå University have succeeded in mapping structures and functions of a transient enzyme state. By modifying the enzyme adenylate kinase, researchers were able to isolate the molecule and study it using the quantitative techniques X-ray crystallography and nuclear magnetic reson ... more

    Aggregated protein in nerve cells can cause ALS

    Persons with the serious disorder ALS, can have a genetic mutation that causes the protein SOD1 to aggregate in motor neurons in the brain and spinal cord. Researchers at Umeå University have discovered that, when injected into mice, the SOD1 aggregation spreads rapidly leading to ALS. ALS, ... more